Valuation: Labcorp Holdings Inc.

Market Cap 25.88B 22.41B 20.95B 19.14B 36.07B 2,469B 36.64B 246B 96.38B 1,235B 97.19B 95.07B 4,113B P/E 2026 *
23.2x
P/E 2027 * 20.6x
Enterprise Value 31.06B 26.89B 25.13B 22.97B 43.29B 2,962B 43.96B 295B 116B 1,482B 117B 114B 4,936B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.96x
Free-Float
99.64%
Yield 2026 *
0.91%
Yield 2027 * 0.92%
1 day-0.04%
1 week+3.66%
Current month+3.06%
1 month+15.12%
3 months+24.93%
6 months+12.01%
Current year+27.02%
1 week 300.58
Extreme 300.58
321.34
1 month 262.1
Extreme 262.105
321.34
Current year 245
Extreme 245
321.34
1 year 244.52
Extreme 244.52
321.34
3 years 191.97
Extreme 191.97
321.34
5 years 191.97
Extreme 191.97
321.34
10 years 98.02
Extreme 98.02
321.34
Date Insider Type Main position Quantity % Market Cap.
04/08/26 Sell

Responsable ventes & marketing

-924 0.0011%
03/08/26 Sell

Controller/Auditor

-4,096 0.0050%
02/07/26 Sell

EVP and President, Diagnostics

-234 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%+3.66%+19.05%+48.90% 25.88B
-1.99%+17.77%+102.75%+496.93% 46.43B
+0.67%+2.47%-19.02%-34.52% 7.76B
+7.49%+14.56%+23.43%+139.82% 5.69B
+1.16%+2.56%+22.50%+63.98% 3.39B
+2.04%+14.05%-29.98%+1,354.79% 2.3B
+0.09%+4.70%+184.97%+17.58% 2.13B
+6.83%+11.49%+2.48%-53.01% 1.99B
+4.04%+15.84%+33.80%-8.80% 1.84B
+3.07%+3.59%+32.08%+185.31% 1.46B
Average +2.22%+9.45%+37.20%+221.10% 9.89B
Weighted average by Cap. +0.29%+12.47%+58.30%+287.05%

Financials

2026 *2027 *
Net sales 14.75B 12.77B 11.93B 10.91B 20.55B 1,407B 20.88B 140B 54.92B 704B 55.38B 54.17B 2,344B 15.46B 13.39B 12.51B 11.44B 21.55B 1,475B 21.89B 147B 57.58B 738B 58.07B 56.8B 2,457B
Net income 1.13B 979M 915M 836M 1.58B 108B 1.6B 10.73B 4.21B 53.93B 4.24B 4.15B 180B 1.24B 1.08B 1.01B 919M 1.73B 118B 1.76B 11.79B 4.63B 59.27B 4.66B 4.56B 197B
Net Debt 5.18B 4.48B 4.19B 3.83B 7.21B 494B 7.33B 49.11B 19.27B 247B 19.44B 19.01B 823B 4.37B 3.78B 3.53B 3.23B 6.08B 416B 6.18B 41.43B 16.26B 208B 16.39B 16.04B 694B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
10/08/26 US$320.51 +0.42% 201,384
07/08/26 US$319.17 +0.83% 429,351
06/08/26 US$316.53 +0.82% 440,062
05/08/26 US$313.96 +0.52% 502,483
04/08/26 US$312.34 +1.60% 748,496
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
319.17USD
Average target price
337.75USD
Spread / Average Target
+5.82%

Quarterly revenue - Rate of surprise